2. UroToday Home
  3. Video Lectures

Imaging: Prostate Cancer

Incorporating Molecular Testing into Clinical Practice for Prostate Cancer - Elena Castro & Collin Pritchard
July 4, 2022
Details
Future Perspectives in Prostate Imaging in Developing Countries - Ronaldo Hueb Baroni
May 23, 2022
Details
Radiotherapy Guided by PSMA PET Molecular Imaging - Juan Galvis Serrano
April 23, 2022
Details
Higher Rates of Metastatic Disease on PSMA PET for Biochemical Recurrence Risk Groups, Journal Club - Christopher Wallis & Zachary Klaassen
April 14, 2022
Details
Results from the Phase 3 SPOTLIGHT Trial of 18F-rhPSMA-7.3 in Recurrent Prostate Cancer - David Schuster
April 14, 2022
Details
The Impact of Imaging and Therapeutics Advances in Nonmetastatic Castration-Resistant Prostate Cancer - David Penson
April 7, 2022
Details
Clinical Trial Equity in Radionuclide Treatment for Prostate Cancer - Joseph Osborne
April 7, 2022
Details
PSMA PET/CT Imaging Indications in Prostate Cancer - Phillip Koo, Neal Shore, & Oliver Sartor
February 11, 2022
Details
NCCN Guidelines On PSMA Molecular Imaging - Tanya Dorff
January 1, 2022
Details
PSMA Imaging - Is Conventional Imaging Obsolete - Steven Rowe
December 26, 2021
Details
Understanding Physiological PSMA Biodistribution - Jeremie Calais
December 6, 2021
Details
F-18-Labeled DCFPyL in Patients With Metastatic Prostate Cancer Undergoing Treatment With ADT – Esther Mena Gonzalez
July 21, 2021
Details
PYLARIFY®, F 18-labeled PSMA Targeted PET Gains US FDA Approval - Michael Morris
May 28, 2021
Details
Bone Imaging in Metastatic Prostate Cancer: A Patient Education Video - Ephraim E. Parent
February 4, 2021
Details
The Accidental Journey of Shepherding PSMA PET Imaging in Prostate Cancer to the Clinic in the United States - Thomas Hope
January 15, 2021
Details
Improving Quality Imaging in Prostate Cancer with Gallium 68 PSMA-11 - Johannes Czernin
January 7, 2021
Details
PSMA PET Imaging for Prostate Cancer Patient Education - Robert Flavell
January 6, 2021
Details
The Impact on Patient Care and Clinical Outcomes Gallium 68 PSMA-11 in Suspected Prostate Cancer Metastasis - Jeremie Calais
December 17, 2020
Details
68Ga-PSMA-11 PET approved in Biochemical Recurrent Prostate Cancer - Jeremie Calais
December 8, 2020
Details
68Ga-PSMA-11 Joins FDA-Approved Tools for Management of Prostate Cancer - Thomas Hope
December 7, 2020
Details
Limitations of PET Imaging in Prostate Cancer - Stefano Fanti
August 29, 2020
Details
CONDOR: Study of 18F-DCFPyL PET/CT Imaging in Patients with Suspected Recurrence of Prostate Cancer - Michael J. Morris
May 28, 2020
Details
68Ga-PSMA PET: A Novel Imaging Technique Prior to Radical Prostatectomy in Men with Intermediate or High Risk Prostate Cancer - Thomas Hope
May 28, 2020
Details
PSMA PET/CT Imaging for Staging High-risk Prostate Cancer Prior to Curative-intent Surgery or Radiotherapy (proPSMA) - Michael Hofman and Declan Murphy
March 23, 2020
Details
Advances in PSMA-directed Radionuclide Therapy - Howard Soule
December 9, 2019
Details
The Use of Novel Imaging Methods in Prostate Cancer - Stefano Fanti
November 18, 2019
Details
Insights on Nuclear Imaging for Prostate Cancer- Stefano Fanti
November 16, 2019
Details
Incorporate Next Generation Imaging Tools Into Clinical Practice - Piet Ost
November 14, 2019
Details
Advantages of PSMA PET in APC Imaging Presentation - Stefano Fanti
October 2, 2019
Details
PSMA PET CT, A Mixed Blessing - Interview with Ian Davis
October 1, 2019
Details
The Future of Advanced Prostate Cancer Imaging Presentation - Stefano Fanti
September 17, 2019
Details
Imaging Bone (Flare) Responses in Advanced Prostate Cancer Presentation - Anwar Padhani
September 17, 2019
Details
Integrating Advanced Molecular Imaging into Clinical Practice - Michael Morris
January 16, 2020
Details
Axumin™ (Fluciclovine F 18) Injection for PET Imaging of Recurrent Prostate Cancer - Phillip Koo
June 21, 2016
Details
email news signup